Snake venoms and the hemostatic system

Toxicon

Volumn 36, Issue 12, 1998, Pages 1749-1800

  Markland, Francis S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; DISINTEGRIN; FIBRIN; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; PHOSPHOLIPASE; PHOSPHOLIPASE INHIBITOR; PLASMINOGEN ACTIVATOR; PROTEIN C; PROTHROMBIN; SERINE PROTEINASE INHIBITOR; SNAKE VENOM; THROMBIN INHIBITOR;

AMINO ACID SEQUENCE; ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CELL ADHESION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; ENZYME DEGRADATION; FIBRIN CLOT; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; ANTICOAGULANTS; BLOOD COAGULATION; ENDOPEPTIDASES; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MOLECULAR SEQUENCE DATA; PLATELET AGGREGATION; PROTEASE INHIBITORS; SNAKE VENOMS;

EID: 0032402107     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00126-3     Document Type: Review

References (304)

1. Adler, M., Lazarus, R. A., Dennis, M. S. and Wagner, G. (1991) Solution structure of kistrin a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist. Science 253, 445-448.
2. Adler, M., Carter, P., Lazarus, R. A. and Wagner, G. (1993) Cysteine pairing in the glycoprotein IIbIIIa antagonist kistrin using NMR, chemical analysis, and structure calculations. Biochemistry 32, 282-289.
3. Ahmed, N. K., Gaddis, R. R., Tennant, K. D. and Lacz, J. P. (1990) Biological and thrombolytic properties of fibrolase: A new fibrinolytic protease from snake venom. Haemostasis 20, 334-340.
4. Almeida, E. A. C., Huovila, A. P. J., Sutherland, A. E., Stephens, L. E., Calarco, P. G., Shaw, L. M., Mercurio, A. M., Sonnenberg, A., Primakoff, P., Myles, D. G., White, J. M. (1995) Mouse egg integrin α6/β1 functions as a sperm receptor. Cell 81, 1095-1104.
5. Andrews, R. K., Kroll, M. H., Ward, C. M., Rose, J. W., Scarborough, R. M., Smith, A. I., Lopez, J. A. and Berndt, M. C. (1996) Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation. Biochemistry 35, 12629-12639.
6. Apprill, P. G., Ashton, J., Guerrero, J., Glas-Greenwalt, P., Buja, L. M. and Willerson, J. T. (1987) Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. Am. Heart J. 113, 898-906.
7. Arocas, V., Zingali, R. B., Guillin, M.-C., Bon, C. and Jandrot-Perrus, M. (1996) Bothrojaracin: A potent two-site-directed thrombin inhibitor. Biochemistry 35, 9083-9089.
8. Arocas, V., Jandrot-Perrus, M., Zingali, R. B., Guillin, M. C., Bon, C. and Wisner, A. (1997) Molecular cloning and expression of the potent thrombin inhibitor bothrojaracin. Thromb. Haemost. Suppl. (Abstracts), 584.
9. Aronson, D. L. (1976) Comparison of the actions of thrombin and the thrombin-like venom enzymes ancrod and batroxobin. Thromb. Haemost. 36, 9-13.
10. 1H NMR and restrained molecular dynamics. Int. J. Pept. Protein Res. 43, 563-572.
11. Atoda, H., Hyuga, M. and Morita, T. (1991) The primary structure of coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. J. Biol. Chem. 266, 14903-14911.
12. Atoda, H. and Morita, T. (1992) Arrangement of the disulfide bridges in a blood coagulation factor IX/Factor X-binding protein from the venom of Trimeresurus flavoviridis. J. Biochem. 113, 159-163.
13. Atoda, H., Yoshida, N., Ishikawa, M. and Morita, T. (1994) Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Eur. J. Biochem. 224, 703-708.
14. Baker, B. J., Wongvibgulsin, S., Nyborg, J. and Tu, A. T. (1995) Nucleotide sequence encoding the snake venom fibrinolytic enzyme atroxase obtained from a Crotalus atrox venom gland cDNA library. Arch. Biochem. Biophys. 317, 357-364.
15. Bajwa, S. S. and Markland, F. S. (1979) A new method for purification of the thrombin-like enzyme from the venom of the eastern diamondback rattlesnake. Thromb. Res. 16, 11-23.
16. Barlow, G. H., Lewis, J. L., Finley, R., Martin, D. and Stocker, K. (1973) Immunochemical identification of ancrod (A38414) and reptilase (defibrase). Thromb. Res. 2, 17-22.
17. Bell, W. R. (1988) Clinical trials with ancrod. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 541-551. Marcel Dekker, New York.
18. Bell, W. R. (1990) Defibrinogenating enzymes. In Hemostasis and Thrombosis, eds R. W. Colman, J. Hirsh, V. J. Marder and E. W. Salzman, pp. 886-900. Lippincott, Philadelphia.
19. Bernabei, A., Gikakis, N., Kowalska, M. A., Niewiarowski, S. and Edmunds, L. H., Jr. (1995) Iloprost and echistatin protect platelets during simulated extracorporeal circulation. Ann. Thorac. Surg. 59, 149-153.
20. Beviglia, L., Stewart, G. J. and Niewiarowski, S. (1995) Effect of four disintegrins on the adhesive and metastatic properties of B16F10 melanoma cells in a murine model. Oncol. Res. 7, 7-20.
21. Bjarnason, J. B., Barish, A., Direnzo, G. S., Campbell, R. and Fox, J. W. (1983) Kallikrein-like enzyme from Crotalus atrox venom. J. Biol. Chem. 258, 12566-12573.
22. Bjarnason, J. B. and Fox, J. W. (1994) Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther. 62, 325-372.
23. Bjarnason, J. B. and Fox, J. W. (1995) Snake venom metalloendopeptidases: Reprolysins. Methods Enzymol. 248, 345-368.
24. Blobel, C. P., Wolfsberg, T. G., Turck, C. W., Myles, D. G., Primakoff, P. and White, J. M. (1992) A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356, 248-252.
25. 2 with anticoagulant activity. II Inhibition of the phospholipid activity in coagulation. Biochim. Biophys. Acta 429, 839-852.
26. Braud, S., Maroun, R. C., Zhang, Y., Bon, C. and Wisner, A. (1997) Structure function of a snake venom plasminogen activator. Thromb. Haemost. Suppl. (Abstracts), 565.
27. Bronson, R. A., Gailit, J., Bronson, S. and Oula, L. (1995) Echistatin, a disintegrin, inhibits sperm-oolemmal adhesion but not oocyte penetration. Fertil. Steril. 64, 414-420.
28. Burkhart, W., Smith, G. F. H., Su, J. L., Parikh, I. and LeVine, H. (1992) Amino acid sequence determination of Ancrod, the thrombin-like α-fibrinogenase from the venom of Akistrodon rhodostoma. FEBS Lett. 297, 297-301.
29. Calvete, J. J., Wang, Y., Mann, K., Schafer, W., Niewiarowski, S. and Stewart, G. J. (1992) The disulfide bridge pattern of snake venom disintegrins, flavoridin and echistatin. FEBS Lett. 309, 316-320.
30. Calvete, J. J., McLane, M. A., Stewart, G. J. and Niewiarowski, S. (1994) Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa. Biochem. Biophys. Res. Commun. 202, 135-140.
31. Catanese, J. and Kress, L. F. (1985) Enzymatic digestion of human plasma inter-α-trypsin inhibitor by snake venom metalloproteinases. Comp. Biochem. Physiol. 80B, 507-512.
32. Cercek, B., Lew, A. S., Hod, H., Yano, J., Lewis, B., Reddy, K. N. N. and Ganz, W. (1987) Ancrod enhances the thrombolytic effect of streptokinase and urokinase. Thromb. Res. 47, 417-426.
33. Chen, Y., Pitzenberger, S. M., Garsky, V. M., Lumma, P. K., Sanyal, G. and Baum, J. (1991) Proton NMR assignments and secondary structure of the snake venom protein echistatin. Biochemistry 30, 11625-11636.
34. Chen, Y.-L. and Tsai, I.-H. (1996) Functional and sequence characterization of coagulation factor IX/factor X-binding protein from the venom of Echis carinatus leucogaster. Biochemistry 35, 5264-5271.
35. Chiang, H. S., Peng, H. C. and Huang, T. F. (1994a) Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion. Biochim. Biophys. Acta 1224, 506-516.
36. Chiang, H. S., Swaim, M. W. and Huang, T. F. (1994b) Characterization of platelet aggregation induced by human colon adenocarcinoma cells and its inhibition by snake venom peptides, trigramin and rhodostomin. Br. J. Haematol. 87, 325-331.
37. Chiang, H. S., Yang, R. S. and Huang, T. F. (1995a) The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cells. Br. J. Cancer 71, 265-270.
38. Chiang, H. S., Swaim, M. W. and Huang, T. F. (1995b) Characterization of platelet aggregation induced by human breast carcinoma and its inhibition by snake venom peptides, trigramin and rhodostomin. Breast Cancer Res. Treat. 33, 225-235.
39. Chiang, H. S., Yang, R. S. and Huang, T. F. (1996) Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin. Br. J. Cancer 73, 902-908.
40. Clark, E. A., Trikha, M., Markland, F. S. and Brugge, J. S. (1994) Structurally distinct disintegrins, contortrostatin and multisquamatin, differentially regulate platelet tyrosine phosphorylation. J. Biol. Chem. 269, 21940-21943.
41. Collen, D. and Lijnen, H. R. (1995) New thrombolytic agents and strategies. Baillieres Clin. Haematol. 8, 425-435.
42. Coller, B. S., Folts, J. D., Smith, S. R., Scudder, L. E. and Jordan, R. (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Circulation 80, 1766-1774.
43. Collins, J. P. and Jones, J. G. (1974) Identification of serine and histidine as essential amino-acid residues in the coagulant enzyme ancrod. Eur. J. Biochem. 42, 81-87.
44. 2. Thromb. Haemost. 45, 82-85.
45. Cook, J. J., Huang, T. F., Rucinski, R., Strzyzewski, M., Tuma, R. F., Williams, J. A. and Niewiarowski, S. (1989) Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. Am. J. Physiol. 256, H1038-1043.
46. Cooke, R. M., Carter, B. G., Murray-Rust, P., Hartshorn, M. J., Herzyk, P. and Hubbard, R. E. (1992) The solution structure of echistatin: Evidence for disulphide bond rearrangement in homologous snake toxins. Protein Eng. 5, 473-477.
47. Damus, P. S., Markland, F. S., Davidson, T. M. and Shanley, J. D. (1972) A purified procoagulant enzyme from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus): In vivo and in vitro studies. J. Lab. Clin. Med. 79, 906-923.
48. Daoud, E., Tu, A. T. and El-Asmar, M. F. (1986) Isolation and characterization of an anticoagulant proteinase, cerastase F-4, from Cerastes cerastes (Egyptian sand viper) venom. Thromb. Res. 42, 55-62.
49. Daoud, E. W., Halim, H. Y., Shaban, E. A. and El-Asmar, M. F. (1987) Further characterization of the anticoagulant proteinase, cerastase F-4 from Cerastes cerastes (Egyptian sand viper) venom. Toxicon 25, 891-897.
50. Daoud, E., Tu, A. T. and El-Asmar, M. F. (1988) The effect of anticoagulant proteinase (Cerastase) from Cerastes cerastes venom on the blood coagulation system. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 241-252. Marcel Dekker, New York.
51. Dennis, M. S., Henzel, W. J., Pitti, R. M., Lipari, M. T., Napier, M. A., Deisher, T. A., Bunting, S. and Lazarus, R. A. (1989) Platelet glycoprotein IIb/IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. 87, 2471-2475.
52. Dennis, M. S., CArter, P. and Lazarus, R. A. (1993) Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: Analysis by site-directed mutagenesis. Proteins Struct. Func. Gen. 15, 312-321.
53. Deshimara, M., Ogawa, T., Nakashima, K.-I., Nobuhisa, I., Chijiwa, T., Shimohigashi, Y., Fukumaki, Y., Niwa, M., Yamashina, I., Hattori, S., Ohno, M. (1996) Accelerated evolution of crotalinae snake venom gland serine proteinases. FEBS Lett. 397, 83-88.
54. Didisheim, P. and Lewis, J. H. (1956) Fibrinolytic and coagulant activities of certain snake venoms and proteases. Proc. Soc. Exp. Biol. Med. 93, 10-13.
55. Di Scipio, R. G., Hermodson, M. A. and Davie, E. W. (1977) Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. Biochemistry 16, 5253-5260.
56. Doolittle, R. F. (1994) Fibrinogen and fibrin. In Haemostass and Thrombosis, eds A. L. Bloom, C. D. Forbes, D. P. Thomas and E. G. D. Tuddenham, Vol. 1, pp. 491-513. Churchill Livingstone, Edinburgh.
57. Ehrly, A. M. (1976) Improvement of the flow properties of blood: A new therapeutical approach in occlusive arterial disease. Angiology 27, 188-196.
58. Eschenfelder, V. (1996) Ancrod as an antithrombotic and thrombolytic agent. In Advances in anticoagulant, antithrombotic and thrombolytic therapeutics, ed. G. Zavoico, pp. 6.8.1-21. IBC Biomedical Library Series, Southborough.
59. Evans, H. J. (1981) Cleavage of the Aα-chain of fibrinogen and the α-polymer of fibrin by the venom of spitting cobra (Naja nigricollis). Biochim. Biophys. Acta 660, 219-226.
60. Evans, H. J. (1984) Purification and properties of a fibrinogenase from the venom of Naja nigricollis. Biochim. Biophys. Acta 802, 49-54.
61. Evans, H. J. and Barrett, A. J. (1988) The action of proteinase F1 from Naja nigricollis venom on the Aα-chain of human fibrinogen. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 213-222. Marcel Dekker, New York.
62. Faili, A., Randon, J., Francischetti, I. M., Vargaftig, B. B. and Hatmi, M. (1994) Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway. Biochem. J. 298, 87-91.
63. Farid, T. M., Tu, A. T. and El-Asmer, M. F. (1990) Effect of cerastobin, a thrombin-like enzyme from Cerastes vipera (Egyptian sand viper) venom, on human platelets. Haemostasis 20, 296-304.
64. Fisher, J. E., Caulfield, M. P., Sato, M., Quartuccio, H. A., Gould, R. J., Garsky, V. M., Rodan, G. A. and Rosenblatt, M. (1993) Inhibition of osteoclastic bone resorption in vivo by echistatin, an 'arginyl-glycyl-aspartyl' (RGD)-containing protein. Endocrinology 132, 1411-1413.
65. Fontana, F. (1787) In Treatise on the Venom of the Viper. Vol. 1. London.
66. Fry, B., Ritter, M. R. and Markland, F. S. (1996) Inhibitory effects of a snake venom protein on the binding of breast cancer cells to extracellular matrix components. Proc. Am. Assoc. Cancer Res. 37, 65.
67. Fujimura, Y., Titani, K., Usami, V., Suzuki, M., Oyama, R., Matsui, T., Fukui, H., Sugimoto, M. and Ruggieri, Z. M. (1991) Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 30, 1957-1964.
68. Fujimura, Y., Ikeda, Y., Miura, S., Yoshida, E., Shima, H., Nishida, S., Suzuki, M., Titani, K., Taniuchi, Y. and Kawasaki, T. (1995) Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb. Haemost. 74, 743-750.
69. Fujimura, Y., Kawasaki, T. and Titani, K. (1996) Snake venom proteins modulating the interaction between von Willebrand factor and platelet glycoprotein Ib. Thromb. Haemost. 76, 633-639.
70. Furie, B. C. and Furie, B. (1976) Coagulant protein of Russell's viper venom. Methods Enzymol. 45, 191-205.
71. Furukawa, K. and Ishimaru, S. (1990) Use of thrombin-like snake venom enzymes in the treatment of vascular occlusive diseases. In Medical Use of Snake Venom Proteins, ed. K. F. Stocker, pp. 161-173. CRC Press, Boca Raton.
72. Gaffney, P. J., Marsh, N. A. and Whaler, B. C. (1973) A coagulant enzyme from Gaboon-viper venom: Some aspects of its mode of action. Biochem. Soc. Transact. 1, 1208-1209.
73. Gan, Z. R., Condra, J. H., Gould, R. J., Zivin, R. A., Bennett, C. D., Jacobs, J. W., Friedman, P. A. and Polokoff, M. A. (1989) High-level expression in Escherichia coli of a chemically synthesized gene for [Leu-28]echistatin. Gene 79, 159-166.
74. Garsky, V. M., Lumma, P. K., Freidinger, R. M., Pitzenberger, S. M., Randall, W. C., Veber, D. F., Gould, R. J. and Friedman, P. A. (1989) Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: Synthesis and biological activity of selected analogs. Proc. Natl. Acad. Sci. 86, 4022-4026.
75. Gasmi, A., Karoui, M., Benlasfar, Z., Karoui, H., El Ayeb, M. and Dellagi, K. (1991) Purification and characterization of a fibrinogenase from Vipera lebetina (desert adder) venom. Toxicon 29, 827-836.
76. Gasmi, A., Guermazi, S., Chabchoub, A., Makni, K., Karoui, H., El Ayeb, M. and Dellagi, K. (1993) Effect of a fibrinogenase from Vipera lebetina venom on human blood coagulation factors and platelets. Toxicon 31, 520.
77. Gasmi, A., Chabchoub, A., Guermazi, S., Karoui, H., Elayeb, M. and Dellagi, K. (1997) Further characterization and thrombolytic activity in a rat model of a fibrinogenase from Vipera lebetina venom. Thromb. Res. 86, 233-242.
78. Gomis-Ruth, F.-X., Kress, L. F. and Bode, W. (1993) First structure of a snake venom metalloproteinase: A prototype for matrix metalloproteinases/collagenases. EMBO J. 12, 4151-4157.
79. Gomis-Ruth, F.-X., Kress, L. F., Kellermann, J., Mayr, I., Lee, X., Huber, R. and Bode, W. (1994) Refined 2.0 A X-ray crystal structure of the snake venom zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin. J. Mol. Biol. 239, 513-544.
80. Gould, R. J., Polokoff, M. A., Friedman, P. A., Huang, T.-F., Holt, J. C., Cook, J. J. and Niewiarowski, S. (1990) Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195, 168-171.
81. Grams, F., Huber, R., Kress, L. F., Moroder, L. and Bode, W. (1993) Activation of snake venom metalloproteinases by a cysteine switch-like mechanism. FEBS Lett. 335, 76-80.
82. Greenberg, C. S. (1994) Fibrin formation and stabilization. In Thrombosis and Hemorrhage, eds J. Loscalzo and A. I. Schafer, pp. 106-126. Blackwell Scientific, Oxford.
83. Guan, L.-F., Chi, C.-W. and Yuan, M. (1984) Study on the thrombin-like enzyme preferentially releasing fibrinopeptide B from the snake venom of Agkistrodon halys pallas. Thromb. Res. 35, 301-310.
84. Guan, A. L., Retzios, A. D., Henderson, G. N. and Markland, F. S. (1991) Purification and characterization of a fibrinolytic enzyme from venom of the southern copperhead snake (Agkistrodon contortrix contortrix). Arch. Biochem. Biophys. 289, 197-207.
85. Hamako, J., Matsui, T., Suzuki, M., Ito, M., Makita, K., Fujimura, Y., Ozeki, Y. and Titani, K. (1996) Purification and characterization of bitiscetin, a novel von Willebrand factor modulator protein from Bitis arietans snake venom. Biochem. Biophys. Res. Commun. 226, 273-279.
86. Herzig, R. H., Ratnoff, O. D. and Shainoff, J. R. (1970) Studies on a procoagulant fractin of southern copperhead snake venom: The preferential release of fibrinopeptide B. J. Lab. Clin. Med. 76, 451-465.
87. Hite, L. A., Shannon, J. D., Bjarnason, J. B. and Fox, J. W. (1992) Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: Evidence for signal, zymogen, and disintegrin-like structures. Biochemistry 31, 6203-6211.
88. Hofman, H. and Bon, C. (1987) Blood coagulation induced by the venom of Bothrops atrox. 2. Identification, purification, and properties of two factor X activators. Biochemistry 26, 780-787.
89. Holahan, M. A., Mellott, M. J., Garsky, V. M. and Shebuski, R. J. (1991) Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis. Pharmacology 42, 340-348.
90. Huang, T. F., Holt, J. C., Kirby, E. R. and Niewiarowski, S. (1989) Trigramin: Primary structure and its inhibition of von Willebrand factor binding to glycoprotein IIb-IIIa complex on human platelets. Biochemistry 28, 661-666.
91. Huang, T. F., Peng, H. C., Peng, I. S., Teng, C. M. and Ouyang, C. (1992) An antiplatelet peptide, gabonin, from Bitis gabonica snake venom. Arch. Biochem. Biophys. 298, 13-20.
92. Huang, T. F., Liu, C. Z. and Yang, S. H. (1995) Aggretin, a novel platelet-aggregation inducer from snake (Calloselasma rhodostoma) venom, activates phospholipase C by acting as a glycoprotein Ia/IIa agonist. Biochem. J. 309, 1021-1027.
93. 2 platelet inhibitor from Ophiophagus hannah (king cobra) venom. Toxicon 35, 492.
94. Hung, C. C., Huang, K. F. and Chiou, S. H. (1994) Characterization of one novel venom protease with β-fibrinogenase activity from the Taiwan habu (Trimeresurus mucrosquamatus): Purification and cDNA sequence analysis. Biochem. Biophys. Res. Commun. 205, 1707-1715.
95. Hutton, R. A. and Warrel, D. A. (1993) Action of snake venom components on the haemostatic system. Blood Rev. 7, 176-189.
96. Itoh, N., Tanaki, N., Mihasi, S. and Yamashina, I. (1987) Molecular cloning and sequence analysis of cDNA for batroxobin, a thrombin-like snake venom enzyme. J. Biol. Chem. 262, 3132-3135.
97. Itoh, N., Tanaka, N., Funakoshi, I., Kawasaki, T., Mihashi, S. and Yamashina, I. (1988) Organization of the gene for batroxobin, a thrombin-like snake venom enzyme. J. Biol. Chem. 263, 7628-7631.
98. Jacobson, M. A., Forma, F. M., Buenaga, R. F., Hofmann, K. J., Schultz, L. D., Gould, R. J. and Friedman, P. A. (1989) Expression and secretion of biologically active echistatin in Saccharomyces cerevisiae. Gene 85, 511-516.
99. Janssen, M., Meier, J. and Freyvogel, T. A. (1992) Purification and characterization of an antithrombin III inactivating enzyme from the venom of the African night adder (Causus rhombeatus). Toxicon 30, 985-999.
100. Jaseja, M., Smith, K. J., Lu, X., Williams, J. A., Trayer, H., Trayer, I. P. and Hyde, E. I. (1993) 1H-NMR studies and secondary structure of the RGD-containing snake toxin, albolabrin. Eur. J. Biochem. 218, 853-860.
101. Jia, L.-G., Wang, X.-M., Shannon, J. D., Bjarnason, J. B. and Fox, J. W. (1997) Function of disintegrin-like/cysteine-rich domain of atrolysin A: Inhibition of platelet aggregation by recombinant protein and peptide antagonists. J. Biol Chem. 272, 13094-13102.
102. Juliano, D., Wang, Y., Marcinkiewicz, C. and Rosenthal, L. A. (1996) Disintegrin interaction with alpha V beta 3 integrin on human umbilical vein endothelial cells: Expression of ligand-induced binding site on beta 3 subunit. Exp. Cell Res. 225, 132-142.
103. Kahn, M. J. P. and Hemker, H. C. (1972) Studies on blood coagulation factor V. V. Changes of molecular weight accompanying activation of factor V by thrombin and the procoagulant protein of Russell's viper venom. Thromb. Diath. Haemost. 27, 25-32.
104. Kaku, S., Umemura, K., Mizuno, A., Kawasaki, T. and Nakashima, M. (1997) Evaluation of the disintegrin, triflavin, in a rat middle cerebral artery thrombosis model. Eur. J. Pharmacol. 321, 301-305.
105. Kamiguti, A. S., Hay, C. R. and Zuzel, M. (1996a) Inhibition of collagen-induced platelet aggregation as the result of cleavage of alpha 2 beta 1-integrin by the snake venom metalloproteinase jararhagin. Biochem. J. 320, 635-641.
106. Kamiguti, A. S., Hay, C. R. M., Theakston, R. D. G. and Zuzel, M. (1996b) Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases. Toxicon 34, 627-642.
107. Kamiguti, A. S., Moura-da-Silva, A. M., Laing, G. D., Knapp, T., Zuzel, M., Crampton, J. M. and Theakston, R. D. (1997) Collagen-induced secretion-dependent phase of platelet aggregation is inhibited by the snake venom metalloproteinase jararhagin. Biochim. Biophys. Acta 1335, 209-217.
108. Kawasaki, T., Taniuchi, Y., Hisamichi, N., Fujimura, Y., Suzuki, M., Titani, K., Sakai, Y., Kaku, S., Satoh, N. and Takenaka, T. et al. (1995) Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation. Biochem. J. 308, 947-953.
109. Kawasaki, T., Fujimura, Y., Usami, Y., Suzuki, M., Miura, S., Sakurai, Y., Makita, K., Taniuchi, Y., Hirano, K. and Titani, K. (1996) Complete amino acid sequence and identification of the platelet glycoprotein Ib-binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J. Biol. Chem. 271, 10635-10639.
110. Kereiakes, D. J., Kleiman, N. S., Ambrose, J., Cohen, M., Rodriguez, S., Palabrica, T., Herrmann, H. C., Sutton, J. M., Weaver, W. D., McKee, D. B., Fitzpatrick, V. and Sax, F. L. (1996) Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. J. Am. Coll. Cardiol. 27, 536-542.
111. King, K. L., DAnza, J. J., Bodary, S., Pitti, R., Siegel, M., Lazarus, R. A., Dennis, M. S., Hammonds, R. G., Jr. and Kukreja, S. C. (1994) Effects of kistrin on bone resorption in vitro and serum calcium in vivo. J. Bone Min. Res. 9, 381-387.
112. 2. Toxicon 27, 613-635.
113. Kini, R. M. and Evans, H. J. (1990) Effects of snake venom proteins on blood platelets. Toxicon 28, 1387-1422.
114. Kini, R. M. and Evans, H. J. (1991) Inhibition of platelet aggregation by a fibrinogenase from Naja nigricollis venom is independent of fibrinogen degradation. Biochim. Biophys. Acta 1095, 117-121.
115. Kini, R. M. and Evans, H. J. (1992) Structural domains in venom proteins: Evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) fron snake venoms are derived by proteolysis from a common precursor. Toxicon 30, 265-293.
116. Kirby, E. P., Niewiarowski, S., Stocker, K., Kettner, C., Shaw, E. and Brudzynski, T. M. (1979) Thrombocytin, a serine protease from Bothrops atrox venom. 1. Purification and characterization of the enzyme. Biochemistry 18, 3564-3570.
117. Kirschbaum, N. E., Reczkowski, R. S. and Budzynski, A. Z. (1988) Secretion of cellular plasminogen activators upon stimulation by Crotalinae snake venoms. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 191-202. Marcel Dekker, New York.
118. Kisiel, W., Hermodson, M. A. and Davie, E. W. (1976) Factor X-activating enzyme from Russell's viper venom: Isolation and characterization. Biochemistry 15, 4901-4906.
119. Kisiel, W. and Canfield, W. M. (1981) Snake venom proteases that activate blood-coagulation factor V. Methods Enzymol. 80, 275-285.
120. Klaus, W., Broger, C., Gerber, P. and Senn, H. (1993) Determination of the disulphide bonding pattern in proteins by local and global analysis of nuclear magnetic resonance data. Application to flavoridin. J. Mol. Biol. 232, 897-906.
121. Klöcking, H. P., Hoffman, A. and Markwardt, F. (1987) Release of plasminogen activator by batroxobin. Haemostasis 17, 235-237.
122. Kondo, H., Kondo, S., Ikezawa, H., Murata, R. and Ohsaka, A. (1960) Studies on the quantitive method for determination of hemorrhagic activity of habu snake venom. Jap. J. Med. Sci. Biol. 13, 43-51.
123. Knight, L. C., Maurer, A. H. and Romano, J. E. (1996) Comparison of iodine-123-disintegrins for imaging thrombi and emboli in a canine model. J. Nucl. Med. 37, 476-482.
124. Kress, L. F. (1986) Inactivation of human plasma serine proteinase inhibitors (Serpins) by limited proteolysis of the reactive site loop with snake venom and bacterial metalloproteinases. J. Cell Biochem. 32, 51-58.
125. Kress, L. F. (1988) The action of snake venom metalloproteinase on plasma proteinase inhibitors. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 335-348. Marcel Dekker, New York.
126. Kress, L. F. and Paroski, E. A. (1978) Enzymatic inactivation of human serum proteinase inhibitors by snake venom proteinases. Biochem. Biophys. Res. Commun. 83, 649-656.
127. Kress, L. F. and Catanese, J. J. (1981) Identification of the cleavage sites resulting from enzymatic inactivation of human antithrobin III by Crotalus adamaanteus proteinase II in the presence and absence of heparin. Biochemistry 20, 7432-7438.
128. 1-proteinase inhibitor by Crotalus adamanteus proteinase II. J. Biol. Chem. 254, 5317-5320.
129. 2-antiplasmin. Biochim. Biophys. Acta 745, 113-120.
130. Kruzel, M. and Kress, L. F. (1985) Separation of Crotalus atrox (western diamondback rattlesnake) α-proteinase from serine proteinase and hemorrhagic factor activities. Anal. Biochem. 151, 471-478.
131. 1-proteinase inhibitor. J. Biol. Chem. 253, 8340-8345.
132. 2 from the venom of the Papuan black snake (Pseudechis papuanus). Biochim. Biophys. Acta 1250, 137-143.
133. Latallo, Z. S. (1983) Retrospective study on complications and adverse effects of treatment with thrombin-like enzymes-a multicentre trial. Thromb. Haemost. 50, 604-609.
134. Lee, W. H., Zhang, Y., Wang, W. Y., Xiong, Y.-L. and Gao, R. (1995) Isolation and properties of a blood coagulation factor X activator from the venom of king cobra (Ophiophagus hannah). Toxicon 33, 1263-1276.
135. a (Activated plasma thromboplastin antecedent and a protease from Russell's viper venom. J. Biol. Chem. 253, 1902-1909.
136. Liu, C. Z. and Huang, T. F. (1997) Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch. Biochem. Biophys. 337, 291-299.
137. Lochnit, G. and Geyer, R. (1995) Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from Bothrops moojeni venom. Eur. J. Biochem. 228, 805-816.
138. Lu, X., Williams, J. A., Deadman, J. J., Salmon, G. P., Kakkar, V. V., Wilkinson, J. M., Baruch, D., Authi, K. S. and Rahman, S. (1994) Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins. Biochem. J. 304, 929-936.
139. Mao, J. P., Wang, W. Y., Xiong, Y. L. and Lu, L. (1995) Fibrinogenase from the venom of Trimeresurus mucrosquamatus. Asiatic Herpetol. Res. 6, 78-84.
140. Marcinkiewicz, C., Rosenthal, L. A., Mosser, D. M., Kunicki, T. J. and Niewiarowski, S. (1996) Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem. J. 317, 817-825.
141. Markland, F. S. (1976) Crotalase. Methods Enzymol. 45, 223-236.
142. Markland, F. S. (1988) Fibrinogenolytic enzymes from snake venoms. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 149-172. Marcel Dekker, New York.
143. Markland, F. S. (1991) Inventory of α and β-fibrinogenases from snake venom. Thromb. Haemost. 65, 438-443.
144. Markland, F. S. (1998) Snake venom fibrinogenolytic and fibrinolytic enzymes: An updated inventory. Thromb. Haemost. 79 (in press).
145. Markland, F. S. and Damus, P. S. (1971) Purification and properties of a thrombin-like enzyme from the venom of Crotalus adamanteus (eastern diamondback rattlesnake). J. Biol. Chem. 246, 6460-6473.
146. Markland, F. S., Kettner, C., Schiffman, S., Shaw, E., Bajwa, S. S., Kirakossian, H., Patkos, G., Theodor, I. and Pirkle, H. (1982) Kallikrein-like action of a fibrinogen clotting snake venom enzyme. Proc. Natl. Acad. Sci. U.S.A. 79, 1688-1692.
147. Markland, F. S., Friedrichs, G. S., Pewitt, S. R. and Lucchesi, B. R. (1994) Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. Circulation 90, 2448-2456.
148. Markland, F. S., Trikha, M., Sudo, Y., Friedrichs, G. R. and Lucchesi, B. R. (1995) Contortrostatin, a disintegrin with potent antiplatelet activity, prevents reocclusion following thrombolysis in a canine carotid artery thrombosis model. Thromb. Haemost. 73, 1314.
149. Marrakchi, N., Zingali, R. B., Karoui, H., Bon, C. and el-Ayeb, M. (1995) Cerastocytin a new thrombin-like platelet activator from the venom of the Tunisian viper Cerastes cerastes. Biochim. Biophys. Acta 1244, 147-156.
150. Marrakchi, N., Barbouche, R., Guermazi, S., Bon, C. and el-Ayeb, M. (1997a) Procoagulant and platelet-aggregating properties of cerastocytin from Cerastes cerastes venom. Toxicon 35, 261-272.
151. Marrakchi, N., Barbouche, R., Bon, C. and el-Ayeb, M. (1997b) Cerastatin, a new potent inhibitor of platelet aggregation from the venom of the Tunisian viper Cerastes cerastes. Toxicon 35, 125-135.
152. Marsh, N. A. (1994) Snake venoms affecting the haemostatic mechanism-a consideration of their mechanisms, practical applications and biological significance. Blood Coagulation Fibrinolysis 5, 399-410.
153. Marsh, N. A. and Whaler, B. C. (1984) The Gaboon viper (Bitis gabonica): Its biology, venom components and toxinology. Toxicon 22, 669-694.
154. Matsuzaki, R., Yoshiara, E., Yamada, M., Shima, K., Atoda, H. and Morita, T. (1996) cDNA cloning of IX/X-BP, a heterogeneous two-chain anticoagulant protein from snake venom. Biochem. Biophys. Res. Commun. 220, 382-387.
155. McLane, M. A., Vijay-Kumar, S., Marcinkiewicz, C., Calvete, J. J. and Niewiarowski, S. (1996) Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha V beta 3 integrins. FEBS Lett. 391, 139-143.
156. Meier, J. (1990) Venomous snakes. In Medical Use of Snake Venom Proteins, ed. K. F. Stocker, pp. 1-32. CRC Press, Boca Raton.
157. Meier, J. and Stocker, K. (1991) Effects of snake venoms on hemostasis. Critical Rev. Toxicol. 21, 171-182.
158. Mitchell, S. W. and Reichert, E. T. (1886) Researches upon the venoms of poisonous serpents. Smithsonian Contributions to Knowledge 26, 1-157.
159. Monteiro, R. Q., Carlini, C. R., Guimaraes, J. A., Bon, C. and Zingali, R. B. (1997) Distinct bothrojaracin isoforms produced by individual jararaca (Bothrops jararaca) snakes. Toxicon 35, 649-657.
160. Moran, J. B. and Geren, C. R. (1981) Characterization of a fibrinogenase from northern copperhead (Agkistrodon contortrix mokasen) venom. Biochim. Biophys. Acta 659, 161-168.
161. Morita, T. and Iwanaga, S. (1978) Purification and proterties of prothrombin activator from the venom of Echis carinatus. J. Biochem. 83, 559-570.
162. Morris, V. L., Schmidt, E. E., Koop, S., MacDonald, I. C., Grattan, M., Khokha, R., McLane, M. A., Niewiarowski, S., Chambers, A. F. and Groom, A. C. (1995) Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res. 219, 571-578.
163. 2. Biochim. Biophys. Acta 1214, 88-96.
164. Moura-da-Silva, A. M., Theakston, R. D. G. and Crampton, J. M. (1996) Evolution of disintegrin cysteine-rich and mammalian matrix-degrading metalloproteinases: Gene duplication and divergence of a common ancestor rather than convergent evolution. J. Mol. Evol. 43, 263-269.
165. Musial, J., Niewiarowski, S., Rucinski, B., Stewart, G. J., Cook, J. J., Williams, J. A. and Edmunds, L. H., Jr. (1990) Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Circulation 82, 261-273.
166. Niewiarowski, S., Kirby, E. P. and Stocker, K. (1977) Thrombocytin-a novel platelet activating enzyme from Bothrops atrox venom. Thromb. Res. 10, 863-869.
167. Niewiarowski, S., Kirby, E. P., Brudzynski, T. M. and Stocker, K. (1979) Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors. Biochemistry 18, 3570-3577.
168. Niewiarowski, S., McLane, M. A., Kloczewiak, M. and Stewart, G. J. (1994) Disintegrins and other naturally occurring antoagonists of platelet fibrinogen receptors. Sem. Hematol. 31, 289-300.
169. Nishida, S., Fujita, T., Kohno, N., Atoda, H., Morita, T., Takeya, H., Kido, I., Paine, M. J., Kawabata, S. and Iwanaga, S. (1995) cDNA cloning and deduced amino acid sequence of prothrombin activator (ecarin) from Kenyan Echis carinatus venom. Biochemistry 34, 1771-1778.
170. Nolan, C., Hall, L. S. and Barlow, G. H. (1976) Ancrod, the coagulating enzyme from Malayan pit viper (Agkistrodon rhodostoma) venom. Methods Enzymol. 45, 205-213.
171. Ohman, E. M., Kleiman, N. S., Gacioch, G., Worley, S. J., Navetta, F. I., Talley, J. D., Anderson, H. V., Ellis, S. G., Cohen, M. D., Spriggs, D., Miller, M., Kereiakes, D., Yakubov, S., Kitt, M. M., Sigmon, K. N., Califf, R. M., Krucoff, M. W. and Topol, E. J. (1997) Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. Circulation 95, 846-854.
172. Ouyang, C. and Teng, C. M. (1972) Purification and properties of the anticoagulant principle from Agkistrodon acutus venom. Biochim. Biophys. Acta 278, 155-162.
173. Ouyang, C. and Huang, T. F. (1977) The properties of the purified fibrinolytic principle from Agkistrodon acutus snake venom. Toxicon 15, 161-167.
174. Ouyang, C. and Huang, T. F. (1983a) A potent platelet aggregation inducer from Trimeresurus gramineus snake venom. Biochim. Biophys. Acta 761, 126-134.
175. Ouyang, C. and Huang, T. F. (1983b) Inhibition of platelet aggregation by 5′-nucleotidase purified from Trimeresurus gramineus snake venom. Toxicon 21, 491-501.
176. Ouyang, C., Jy, W., Zan, Y. P. and Teng, C. M. (1981) Mechanism of the anticoagulant action of phospholipase A purified from Trimeresurus mucrosquamatus (Formosan habu) snake venom. Toxicon 19, 113-120.
177. Ouyang, C., Hwang, L. J. and Huang, T. F. (1985) Inhibition of rabbit platelet aggregation by alpha-fibrinogenase purified from Calloselasma rhodostoma (Malayan pit viper) venom. J. Formosan Med. Assoc. 84, 1197-1206.
178. Ouyang, C., Teng, C. M. and Huang, T. F. (1992) Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 30, 945-966.
179. Paine, M. J. I., Desmond, H. P., Theakston, R. D. G. and Cramption, J. M. (1992) Purification, cloning, and molecular weight characterization of a high molecular weight hemorrhagic metalloproteinase, jararhagin, from Bothrops jararaca venom. J. Biol. Chem. 267, 22869-22876.
180. Peng, M., Lu, W. and Kirby, E. P. (1991) Alboaggregin-B: A new platelet agonist that binds to platelet membrane glycoprotein Ib. Biochemistry 30, 11529-11536.
181. Peng, M., Lu, W. and Kirby, E. P. (1992) Characterization of three alboaggregins purified from Trimeresurus albolabris venom. Thromb. Haemost. 67, 702-707.
182. Peng, M., Lu, W., Beviglia, L., Niewiarowski, S. and Kirby, E. P. (1993) Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 81, 2321-2328.
183. Peng, M., Holt, J. C. and Niewiarowski, S. (1994) Isolation, characterization and amino acid sequence of echicetin beta subunit, a specific inhibitor of von Willebrand factor and thrombin interaction with glycoprotein Ib. Biophys. Res. Commun. 205, 68-72.
184. Peng, M., Emig, F. A., Mao, A., Lu, W., Kirby, E. P., Niewiarowski, S. and Kowalska, M. A. (1995) Interaction of echicetin with a high affinity thrombin binding site on platelet glycoprotein GPIb. Thromb. Haemost. 74, 954-957.
185. Perutelli, P. (1995) Le disintegrine: Potenti inhibitori dell aggregazione piastrinica. Recenti Progressi in Medicina 86, 168-174.
186. Pfaff, M., McLane, M. A., Beviglia, L., Niewiarowski, S. and Timpl, R. (1994) Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Cell Adhes. Commun. 2, 491-501.
187. Pfeiffer, G., Dabrowski, U., Dabrowski, J., Stirm, S., Strube, K.-H. and Geyer, R. (1992) Carbohydrate structure of a thrombin-like serine protease from Agkistrodon rhodostoma. Structure elucidation of oligosaccharides by methylation analysis, liquid secondary-ion mass spectrometry and proton magnetic resonance. Eur. J. Biochem. 205, 961-978.
188. Pfeiffer, G., Linder, D., Strube, K.-H. and Geyer, R. (1993) Glycosylation of the thrombin-like serine protease ancrod from Agkistrodon rhodostoma venom. Oligosaccharide substitution pattern at each N-glycosylation site. Glycoconjugate J. 10, 240-246.
189. Pirkle, H. (1998) Thrombin-like venom enzymes from snake venoms: An updated inventory. Thromb. Haemost. (in press).
190. Pirkle, H. and Theodor, I. (1990) Thrombin-like venom enzymes: Structure and function. Adv. Exp. Med. Biol. 281, 165-175.
191. Pirkle, H. and Markland, F. S. (1997) Venombin AB. In Handbook of Proteolytic Enzymes, eds A. J. Barrett and J. F. Woessner. Academic Press, London, in press.
192. Pirkle, H. and Theodor, I. (1998) Thrombin-like enzymes. In The Enzymology of Snake Venoms, ed. G. S. Bailey. Alaken, Fort Collins (in press).
193. Pirkle, H., Theodor, I., Miyada, D. and Simmons, G. (1986) Thrombin-like enzyme from the venom of Bitis gabonica: Purification, properties, and coagulant actions. J. Biol. Chem. 261, 8830-8835.
194. Pirkle, H., Theodor, I. and Henschen, A. (1996) Crotalase, a fibrinogen-clotting venom enzyme: Primary structure and evidence for lack of a fibrinogen recognition exosite homologous to that of thrombin. Thromb. Haemost. 26(Suppl. 2), 452.
195. Pitney, W. R. and Regoeczi, E. (1970) Inactivation of 'Arvin' by plasma proteins. Br. J. Haematol. 19, 67-81.
196. Polgar, J., Clemetson, J. M., Kehrel, B. E., Wiedemann, M., Magnenat, E. M., Wells, T. N. C. and Clemetson, K. J. (1997a) Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J. Biol. Chem. 272, 13576-13583.
197. Polgar, J., Magnenat, E. M., Peitsch, M. C., Wells, T. N., Saqi, M. S. and Clemetson, K. J. (1997b) Amino acid sequence of the alpha subunit and computer modelling of the alpha and beta subunits of echicetin from the venom of Echis carinatus (saw-scaled viper). Biochem. J. 323, 533-537.
198. Pollack, V. E., Glas-Greenwalt, P., Olinger, C. P., Wadhwa, N. K. and Myre, S. A. (1990) Ancrod causes rapid thrombolysis in patients with acute stroke. Am. J. Med. Sci. 299, 319-325.
199. 2 from Russell's viper (Vipera russelli) venom: Isolation and characterization. Toxicon 34, 1173-1185.
200. Prentice, C. R. M., Hampton, K. K., Grant, P. J., Nelson, S. R., Nieuwenhuizen, W. and Gaffney, P. J. (1993) The fibrinolytic response to ancrod therapy: Characterization of fibrinogen and fibrin degradation products. Br. J. Haematol. 83, 276-281.
201. Pretzer, D., Schulteis, B. S., Smith, C. D., Vander Velde, D. G., Mitchell, J. W. and Manning, M. C. (1993) Fibrolase. A fibrinolytic protein from snake venom. Pharmac. Biotechnol. 5, 287-314.
202. Rahman, S., Lu, X., Kakkar, V. V. and Authi, K. S. (1995) The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD. Biochem. J. 312, 223-232.
203. Randolph, A., Chamberlain, S. H., Chu, C., Retzios, A. D., Markland, F. S. and Masiarz, F. R. (1992) Amino acid sequence of fibrolase, a direct-acting fibrinolytic enzyme from Agkistrodon contortrix contortrix venom. Protein Sci. 1, 590-600.
204. Read, M. S., Shermer, R. W. and Brinkhous, K. M. (1978) Venom coagglutin: An activator of platelet aggregation dependent on von Willebrand factor. Proc. Natl. Acad. Sci. U.S.A. 75, 4514-4518.
205. Retzios, A. D. and Markland, F. S. (1988) A direct-acting fibrinolytic enzyme from the venom of Agkistrodon contortrix contortrix: Effects on various components of the human blood coagulation and fibrinolytic systems. Thromb. Res. 52, 541-552.
206. Retzios, A. D. and Markland, F. S. (1992) Purification, characterization, and fibrinogen cleavage sites of three fibrinolytic enzymes from the venom of Crotalus basiliscus basiliscus. Biochemistry 31, 4547-4557.
207. Romson, J. L., Haack, D. W. and Lucchesi, B. R. (1980) Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for in vivo evaluation of anti-thrombotic agents. Thromb. Res. 17, 841-853.
208. Rosenfeld, G., Nahas, L. and Kelen, E. M. A. (1968) Coagulant, proteolytic, and hemolytic properties of some snake venoms. In Venomous Animal and Their Venoms, eds W. Bücherl, E. Buckley and V. Deulofeu, pp. 229-273. Academic Press, New York.
209. Rosing, T. and Tans, G. (1991) Inventory of exogenous prothrombin activators. Thromb. Haemost. 65, 627-630.
210. Rosing, J. and Tans, G. (1992) Structural and functional properties of snake venom prothrombin activators. Toxicon 30, 1515-1527.
211. Rosing, J., Zwaal, R. F. A. and Tans, G. (1988) Snake venom prothrombin activators. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 3-27. Marcel Dekker, New York.
212. Rote, W. E., Mu, D. X. and Lucchesi, B. R. (1993) Thromboxane antagonism in experimental canine carotid artery thrombosis. Stroke 24, 820-828.
213. Russell, F. E. (1980) Venoms. In Snake Venom Poisoning, pp. 139-234. Lippincott, Philadelphia.
214. Sanchez, E. F., Diniz, C. R. and Richardson, M. (1991) The complete amino acid sequence of the hemorrhagic factor LHFII, a metalloproteinase isolated from the venom of the bushmaster snake (Lachesis muta muta). FEBS lett. 282, 176-182.
215. Sanchez, E. F., Bush, L. R., Swenson, S. and Markland, F. S. (1997) Chimeric fibrolase: Covalent attachment of an RGD-like peptide to create a potentially more effective thrombolytic agent. Thromb. Res. 87, 289-302.
216. Sato, M., Sardana, M. K., Grasser, W. A., Garsky, V. M., Murray, J. M. and Gould, R. J. (1990) Echistatin is a potent inhibitor of bone resorption in culture. J. Cell Biol. 111, 1713-1723.
217. Sato, M., Garsky, V., Majeska, R. J., Einhorn, T. A., Murray, J., Tashjian, A. H., Jr. and Gould, R. J. (1994) Structure-activity studies of the s-echistatin inhibition of bone resorption. J. Bone Miner. Res. 9, 1441-1449.
218. 1H-NMR, circular dichroism and Raman spectroscopy. Europ. J. Biochem. 202, 329-338.
219. Saudek, V., Atkinson, R. A. and Pelton, J. T. (1991b) Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 30, 7369-7372.
220. Scaloni, A., Di-Martino, E., Miraglia, N., Pelagalli, A., Della-Morte, R., Staiano, N. and Pucci, P. (1996) Amino acid sequence and molecular modelling of glycoprotein IIb-IIIa and fibronectin receptor iso-antagonists from Trimeresurus elegans venom. Biochem. J. 319, 775-782.
221. Scarborough, R. M., Hsu, M. A., Teng, W., Nannizzi, L. and Rose, J. W. (1991a) Purification and characterization of potent inhibitors of von Willebrand factor binding to glycoprotein (GP) Ib from the venom of the timber rattlesnake, Crotalus h. horridus. Blood 78(Suppl. 1), 394a.
222. Scarborough, R. M., Rose, J. W., Hsu, M. A., Phillips, D. R., Fried, V. A., Campbell, A. M., Nannizzi, L. and Charo, I. F. (1991b) A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 266, 9359-9362.
223. Scarborough, R. M., Rose, J. W., Naughton, M. A., Phillips, D. R., Nannizzi, L., Arfsten, A., Campbell, A. M. and Charo, I. F. (1993) Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms. J. Biol. Chem. 268, 1058-1065.
224. Schiffman, S., Theodor, I. and Rapaport, S. I. (1969) Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry 8, 1397-1404.
225. Schmaier, A. H. and Colman, R. W. (1980) Crotalocytin: Characterization of the timber rattlesnake platelet activating protein. Blood 56, 1020-1028.
226. Schmaier, A. H., Claypool, W. and Colman, R. W. (1980) Crotalocytin: Recognition and purification of a timber rattlesnake platelet aggregating protein. Blood 56, 1013-1019.
227. Sekiya, F., Atoda, H. and Morita, T. (1993) Isolation and characterization of an anticoagulant protein homologous to botrocetin from the venom of Bothrops jararaca. Biochemistry 32, 6892-6897.
228. Sekiya, F., Yamashita, T. and Morita, T. (1995) Role of calcium (II) ions in the recognition of coagulation factors IX and X by IX/X-bp, an anticoagulant from snake venom. Biochemistry 34, 10043-10047.
229. Selistre-de-Araujo, H. S. and Ownby, C. L. (1995) Molecular cloning and sequence analysis of cDNAs for metalloproteinases from broad-banded copperhead Agkistrodon contortrix laticinctus. Arch. Biochem. Biophys. 320, 141-148.
230. Senn, H. and Klaus, W. (1993) The nuclear magnetic resonance solution structure of flavoridin, an antagonist of the platelet GP IIb-IIIa receptor. J. Mol. Biol. 232, 907-925.
231. Shainoff, J. R. and Welches, W. R. (1988) Studies of the preferential release of fibrinopeptide B by copperhead procoagulant enzyme. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 85-92. Marcel Dekker, New York.
232. Shebuski, R. J., Stabilito, I. J., Sitko, G. R. and Polokoff, M. H. (1990) Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis. Circulation 82, 169-177.
233. Sherman, D. G. and the Ancrod Stroke Study Investigators (1994) Ancrod for the treatment of acute ischemic brain infarction. Stroke 25, 1755-1759.
234. Sherry, S. (1990) Bleeding complications in thrombolytic therapy. Hospital Practice 25(Suppl. 5), 1-21.
235. Sheu, J. R., Lin, C. H., Peng, H. C. and Huang, T. F. (1994a) Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism. Peptides 15, 1391-1398.
236. Sheu, J. R., Lin, C. H. and Huang, T. F. (1994b) Triflavin, an antiplatelet peptide, inhibits tumor cell-extracellular matrix adhesion through an arginine-glycine-aspartic acid-dependent mechanism. J. Lab. Clin. Med. 123, 256-263.
237. Sheu, J. R., Lin, C. H., Peng, H. C. and Huang, T. F. (1996) Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc. Soc. Exp. Biol. Med. 213, 71-79.
238. Shimokawa, K.-I., Jia, L.-G., Wang, X.-M. and Fox, J. W. (1996) Expression, activation, and processing of the recombinant snake venom metalloproteinase, pro-atrolysin E. Arch. Biochem. Biophys. 335, 283-294.
239. Shimokawa, K., Shannon, J. D., Jia, L. G. and Fox, J. W. (1997) Sequence and biological activity of catrocollastatin-C: A disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch. Biochem. Biophys. 343, 35-43.
240. Siigur, E. and Siigur, J. (1991) Purification and characterization of lebetase, a fibrinolytic enzyme from Vipera lebetina (snake) venom. Biochim. Biophys. Acta 1074, 223-229.
241. Siigur, J. and Siigur, E. (1992) The direct acting α-fibrin(ogen)olytic enzymes from snake venoms. J. Toxicol. Toxin. Rev. 11, 91-113.
242. Siigur, E., Aaspollu, A., Tu, A. T. and Siigur, J. (1996) cDNA cloning and deduced amino acid sequence of fibrinolytic enzyme (lebetase) from Vipera lebetina snake venom. Biochem. Biophys. Res. Commun. 224, 229-236.
243. Smith, S. C. and Brinkous, K. M. (1991) Inventory of exogenous platelet-aggregating agents derived from venoms. Thromb. Haemost. 66, 259-263.
244. 1H NMR spectroscopy and simulated annealing calculations. Int. J. Peptide Protein Res. 48, 220-228.
245. Soszka, T., Kirschbaum, N. E., Stewart, G. J. and Budzynski, A. Z. (1985) Direct effect of fibrinogen-clotting enzymes on plasminogen activator secretion from human endothelial cells. Thromb. Haemost. 54, 164.
246. Soszka, T., Knudsen, K. A., Beviglia, L., Rossi, C., Poggi, A. and Niewiarowski, S. (1991) Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris. Exp. Cell Res. 196, 6-12.
247. Soutar, R. L. and Ginsberg, J. S. (1993) Anticoagulant therapy with ancrod. Clinical Rev. Oncology/Hematology 15, 23-33.
248. Staiano, N., Villani, G. R., Di-Martino, E., Squillacioti, C., Vuotto, P. and Di-Natale, P. (1995) Echistatin inhibits the adhesion of murine melanoma cells to extracellular matrix components. Biochem. Mol. Biol. Int. 35, 11-19.
249. Stocker, K. F. (1988) Clinical trials with batroxobin. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 525-540. Marcel Dekker, New York.
250. Stocker, K. (1990a) Composition of snake venoms. In Medical Use of Snake Venom Proteins, ed. K. F. Stocker, pp. 33-56. CRC Press, Boca Raton.
251. Stocker, K. (1990b) Snake venom protein affecting hemostasis and fibrinolysis. In Medical Use of Snake Venom Proteins, ed. K. F. Stocker, pp. 97-160. CRC Press, Boca Raton.
252. Stocker, K. (1994) Inventory of exogenous hemostatic factors affecting the prothrombin activating pathways. Thromb. Haemost. 71, 257-260.
253. Stocker, K. and Barlow, G. H. (1976) The coagulant enzyme from Bothrops atrox venom (Batroxobin). Methods Enzymol. 45, 214-223.
254. Stocker, K. F. and Meier, K. (1988) Thrombin-like snake venom enzymes. In Hemostasis and Animal Venoms, eds H. Pirkle and F. S. Markland, pp. 67-84. Marcel Dekker, New York.
255. Stocker, K., Fischer, H. and Meier, J. (1982) Thrombin-like snake venom proteinases. Toxicon 20, 265-273.
256. Stocker, K., Fischer, H., Meier, J., Brogli, M. and Svendsen, L. (1986) Protein C activators in snake venoms. Behring Inst. Mitt. 79, 37-47.
257. Stocker, K., Fischer, H., Meier, J., Brogli, M. and Svendsen, L. (1987) Characterization of the protein C activator protac from venom of the southern copperhead (Agkistrodon contortrix) snake. Toxicon 23, 239-252.
258. Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F.-X., McKay, D. B. and Bode, W. (1995) The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Science 4, 823-840.
259. Subburaju, S. and Kini, R. M. (1997) Isolation and purification of superbins I and II from Austrelelaps superbus (copperhead) snake venom and their anticoagulant and antiplatelet effects. Toxicon 35, 1239-1250.
260. Sugiki, M., Maruyama, M., Yoshida, E., Miharaa, H., Kamiguti, A. S. and Theakston, R. D. G. (1995) Enhancement of plasma fibrinolysis in vitro by jararhagin, the main hemorrhagic metalloproteinase in Bothrops jararaca venom. Toxicon 33, 1605-1617.
261. Sugimoto, M., Mohri, H., McClintock, R. A. and Ruggeri, Z. M. (1991) Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib. J. Biol. Chem. 266, 18172-18178.
262. Sunagawa, M., Hanashiro, K., Nakamura, M. and Kosugi, T. (1996) Habutoxin releases plasminogen activator (u-PA) from bovine pulmonary artery endothelial cells. Toxicon 34, 691-699.
263. Suzuki, K. (1995) Protein C. In Molecular Basis of Thrombosis and Hemostasis, eds K. A. High and H. R. Roberts, pp. 393-424. Marcel Dekker, New York.
264. 2-macroglobulin inactivating enzymes from the venom of the mexican west coast rattlesnake (Crotalus basiliscus). Toxicon 33, 1331-1346.
265. 2 that induces platelet aggregation. Toxicon 26, 199-206.
266. Takeya, H. and Iwanaga, S. (1994) Snake venom hemorrhagic and non-hemorrhagic metalloproteinases: Their structure and function relationships. In Biological Functions of Proteinases and Inhibitors, eds M. Katunuma, et al., pp. 231-252. Karger, Basel.
267. Takeya, H., Nishida, S., Miyata, T., Kawada, S., Saisaka, Y., Morita, T. and Iwanaga, S. (1992) Coagulation factor X-activating enzyme from Russell's viper venom, (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J. Biol. Chem. 267, 14109-14117.
268. Tanaka, N., Nakada, H., Itoh, N., Mizuno, Y., Takanishi, M., Kawasaki, T., Tate, S.-I., Inagami, F. and Yamashina, I. (1992) Novel structure of the N-acetylgalactosamine containing N-glycosidic carbohydrate chain of batroxobin, a thrombin-like snake venom enzyme. J. Biochem. 112, 68-74.
269. Taniuchi, Y., Kawasaki, T., Fujimura, Y., Suzuki, M., Titani, K., Sakai, Y., Kaku, S., Hisamichi, N., Satoh, N. and Takenaka, T. et al. (1995) Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochim. Biophys. Acta 1244, 331-338.
270. Tcheng, J. E. (1996) Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE and EPILOG trials into perspective. Am. J. Cardiol. 78(Suppl. 3A), 35-40.
271. Teng, C.-M. and Ko, F.-N. (1988) Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin. Thromb. Haemost. 59, 304-309.
272. Teng, C.-M. and Seegers, W. H. (1991) Agkistrodon acutus snake venom inhibits prothrombinase complex formation. Thromb. Res. 23, 255-263.
273. Teng, C.-M. and Huang, T.-F. (1991) Inventory of exogenous inhibitors of platelet aggregation. Thromb. Haemost. 65, 624-626.
274. Teng, C. M., Chen, Y. H. and Ouyang, C. (1984) Biphasic effect on platelet aggregation by phospholipase a purified from Vipera russellii snake venom. Biochim. Biophys. Acta 772, 393-402.
275. Teng, C.-M., Ouyang, C. and Lin, S. C. (1985) Species difference in the fibrinogenolytic effects of α- and β-fibrinogenases from Trimeresurus mucrosquamatus snake venom. Toxicon 23, 777-782.
276. 2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophophatidylcholine. Thromb. Res. 44, 875-886.
277. Teng, C. M., Hung, M. L., Huang, T. F. and Ouyang, C. (1989) Triwaglerin: A potent platelet aggregation inducer purified from Trimeresurus wagleri snake venom. Biochim. Biophys. Acta 992, 258-264.
278. Teng, C. M., Ko, F. N., Tsai, I. H., Hung, M. L. and Huang, T. F. (1993) Trimucytin: A collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom. Thromb. Haemost. 69, 286-292.
279. Thomson, N. C., Hutcheon, A. W. and Dagg, J. H. (1977) Multiple courses of ancrod (Arvin) therapy. Br. Med. J. 1, 508.
280. Tokunaga, F., Nagasawa, K., Tamura, S., Miyata, T., Iwanaga, S. and Kisiel, W. (1988) The factor V-activating enzyme (RVV-V) from Russell's viper venom. Identification of isoproteins RVV-Vα, -Vβ, and -Vγ and their complete amino acid sequences. J. Biol. Chem. 263, 17471-17481.
281. Tomaru, T., Uchida, Y., Sonoki, H. and Sugimoto, T. (1988) Preventive effects of batroxobin on experimental canine coronary thrombosis. Clin. Cardiol. 11, 223-230.
282. Trikha, M., De Clerck, Y. A. and Markland, F. S. (1994a) Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion, and blocks experimental metastasis. Cancer Res. 54, 4993-4998.
283. Trikha, M., Rote, W. E., Manley, P. J., Lucchesi, B. R. and Markland, F. S. (1994b) Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb. Res. 73, 39-52.
284. Tu, A. T. (1988a) Snake venoms: General background and composition. In Venoms: Chemistry and Molecular Biology, pp. 1-19. John Wiley and Sons, New York.
285. Tu, A. T. (1988b) Overview of snake venom chemistry. Adv. Exp. Med. Biol. 391, 37-62.
286. Usami, Y., Fujimura, Y., Miura, S., Shima, H., Yoshida, E., Yoshioka, A., Hirano, K., Suzuki, M. and Titani, K. (1994) A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen and ADP-induced platelet aggregation. Biochem. Biophys. Res. Commun. 201, 331-339.
287. Weskamp, G. and Blobel, C. P. (1994) A family of cellular proteins related to snake venom disintegrins. Proc. Natl. Acad. Sci. 91, 2748-2751.
288. Williams, J. A. (1992) Disintegrins: RGD-containing proteins which inhibit cell/matrix interactions (adhesion) and cell/cell interactions (aggregation) via their integrin receptors. Pathol. Biol. 40, 813-821.
289. Willis, T. W. and Tu, A. T. (1988) Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrinolytic protease from western diamondback rattlesnake venom. Biochemistry 27, 4769-4777.
290. Willis, T. W., Tu, A. T. and Miller, C. W. (1989) Thrombolysis with a snake venom protease in a rat model of venous thrombosis. Thromb. Res. 53, 19-29.
291. Wright, P. S., Saudek, V., Owen, T. J., Harbeson, S. L. and Bitonti, A. J. (1993) An echistatin C-terminal peptide activates GPIIb/IIIa binding to fibrinogen, fibronectin, vitronectin and collagens type I and type IV. Biochem. J. 293, 263-267.
292. Yamada, T. and Kidera, A. (1996) Tailoring echistatin to possess higher affinity for integrin alpha(IIb)beta(3). FEBS Lett. 387, 11-15.
293. Yamada, D., Sekiya, F. and Morita, T. (1996) Isolation and characterization of carinactivase, a novel prothrombin activator in Echis carinatus venom with a unique catalytic mechanism. J. Biol. Chem. 271, 5200-5207.
294. Yang, C. H., Huang, T. F., Liu, K. R., Chen, M. S. and Hung, P. T. (1996) Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom. Invest. Ophthalmol. Vis. Sci. 37, 843-854.
295. Yasuda, T., Gold, H. K., Leinbach, R. C., Yaoita, H., Fallon, J. T., Guerrero, L., Napier, M. A., Bunting, S. and Collen, D. (1991) Kistrin, a polypeptide platelet GPIIb/IIIa receptor antagonist, enhances and sustains coronary arterial thrombolysis with recombinant tissue-type plasminogen activator in a canine preparation. Circulation 83, 1038-1047.
296. Yoshida, E., Fujimura, Y., Miura, S., Sugimopto, M., Fukui, H., Narita, N., Usami, Y., Suzuki, M. and Titani, K. (1993) Alboaggregin S and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem. Biophys. Res. Commun. 191, 1386-1392.
297. 2: A potent inhibitor of platelet aggregation. Thromb. Res. 70, 471-481.
298. Zhang, Y., Wisner, A., Xiong, Y. and Bon, C. (1993) svPA, a specific plasminogen activator from the venom of Trimeresurus stejnegeri. Toxicon 31, 539.
299. Zhang, Y., Xiong, Y. L. and Bon, C. (1995a) An activator of blood coagulation factor X from the venom of Bungarus fasciatus. Toxicon 33, 1277-1288.
300. Zhang, Y., Wisner, A., Xiong, Y. and Bon, C. (1995b) A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning. J. Biol. Chem. 270, 10246-10255.
301. Zhou, Q., Smith, J. B. and Grossman, M. H. (1995) Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen. Biochem. J. 307, 411-417.
302. Zhou, Q., Ritter, M. and Markland, F. S. (1996a) Contortrostatin, a snake venom protein, which is an inhibitor of breast cancer progression. Molecular Biol. Cell 7, 425a.
303. Zhou, Q., Dangelmaier, C. and Smith, J. B. (1996b) The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain. Biochem. Biophys. Res. Commun. 219, 720-726.
304. Zingali, R. B., Jandrot-Perrus, M., Guilin, M.-C. and Bon, C. (1993) Bothrojararacin, a new thrombin inhibitor isolated from Bothrops jararaca venom: Characterization and mechanism of thrombin inhibition. Biochemistry 32, 10794-10802.